Sarah Oelsner

899 total citations
8 papers, 758 citations indexed

About

Sarah Oelsner is a scholar working on Immunology, Oncology and Genetics. According to data from OpenAlex, Sarah Oelsner has authored 8 papers receiving a total of 758 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 7 papers in Oncology and 2 papers in Genetics. Recurrent topics in Sarah Oelsner's work include Immune Cell Function and Interaction (8 papers), CAR-T cell therapy research (7 papers) and Immunotherapy and Immune Responses (2 papers). Sarah Oelsner is often cited by papers focused on Immune Cell Function and Interaction (8 papers), CAR-T cell therapy research (7 papers) and Immunotherapy and Immune Responses (2 papers). Sarah Oelsner collaborates with scholars based in Germany, United Kingdom and United States. Sarah Oelsner's co-authors include Winfried S. Wels, Congcong Zhang, Torsten Tonn, Pranav Oberoi, Anja Waldmann, Peter Bader, Evelyn Ullrich, Sabrina Genßler, Michael C. Burger and Jörg Steinbach and has published in prestigious journals such as International Journal of Cancer, Frontiers in Immunology and Oncotarget.

In The Last Decade

Sarah Oelsner

8 papers receiving 741 citations

Peers

Sarah Oelsner

ONCOL

IMMUN

MB

GENET

BE

Yaya Chu United States

Tamara Laskowski United States

James Dongjoo Ham United States

Kevin M. Friedman United States

Marine Cazaux France

Rama Shivakumar United States

Pranav Oberoi Germany

Ranjan Upadhyay United States

Alexander Biederstädt Germany

Caroline Arber United States

Yaya Chu United States

Sarah Oelsner

463 ×0.7

ONCOL

431 ×0.7

IMMUN

131 ×1.0

MB

72 ×0.7

GENET

35 ×0.5

BE

Citations per year, relative to Sarah Oelsner Sarah Oelsner (= 1×) peers Yaya Chu

Countries citing papers authored by Sarah Oelsner

Since Specialization

Citations

This map shows the geographic impact of Sarah Oelsner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Oelsner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Oelsner more than expected).

Fields of papers citing papers by Sarah Oelsner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Oelsner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Oelsner. The network helps show where Sarah Oelsner may publish in the future.

Co-authorship network of co-authors of Sarah Oelsner

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Oelsner. A scholar is included among the top collaborators of Sarah Oelsner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Oelsner. Sarah Oelsner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Oelsner, Sarah, Anja Waldmann, Jasmin Röder, et al.. (2019). Genetically engineered CAR NK cells display selective cytotoxicity against FLT3‐positive B‐ALL and inhibit in vivo leukemia growth. International Journal of Cancer. 145(7). 1935–1945. 71 indexed citations

2.

Zhang, Congcong, Pranav Oberoi, Sarah Oelsner, et al.. (2017). Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity. Frontiers in Immunology. 8. 533–533. 258 indexed citations

3.

Oelsner, Sarah, Simone Fulda, Thomas Klingebiel, et al.. (2017). Generation and characterization of ErbB2-CAR-engineered cytokine-induced killer cells for the treatment of high-risk soft tissue sarcoma in children. Oncotarget. 8(39). 66137–66153. 31 indexed citations

4.

Oelsner, Sarah, Miriam E. Friede, Congcong Zhang, et al.. (2016). Continuously expanding CAR NK-92 cells display selective cytotoxicity against B-cell leukemia and lymphoma. Cytotherapy. 19(2). 235–249. 159 indexed citations

5.

Oelsner, Sarah, Juliane Wagner, Miriam E. Friede, et al.. (2016). Chimeric antigen receptor‐engineered cytokine‐induced killer cells overcome treatment resistance of pre‐B‐cell acute lymphoblastic leukemia and enhance survival. International Journal of Cancer. 139(8). 1799–1809. 51 indexed citations

6.

Oelsner, Sarah, Eva Rettinger, Sabine Huenecke, et al.. (2015). Cytomegalovirus-specific cytokine-induced killer cells: concurrent targeting of leukemia and cytomegalovirus. Cytotherapy. 17(8). 1139–1151. 17 indexed citations

7.

Genßler, Sabrina, Michael C. Burger, Congcong Zhang, et al.. (2015). Dual targeting of glioblastoma with chimeric antigen receptor-engineered natural killer cells overcomes heterogeneity of target antigen expression and enhances antitumor activity and survival. OncoImmunology. 5(4). e1119354–e1119354. 155 indexed citations

8.

Rettinger, Eva, Behnaz Ahangarian Abhari, Sarah Oelsner, et al.. (2014). SMAC Mimetic BV6 Enables Sensitization of Resistant Tumor Cells but also Affects Cytokine-Induced Killer (CIK) Cells: A Potential Challenge for Combination Therapy. Frontiers in Pediatrics. 2. 75–75. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact